Early changes in cytokines, chemokines and indices of bone metabolism in a phase 2 study of the bruton tyrosine kinase (Btk) inhibitor, ibrutinib (PCI-32765) in patients with relapsed or relapsed/refractory multiple myeloma (MM) Meeting Abstract
| Authors: | Vij, R.; Chang, B. Y.; Berdeja, J. G.; Huff, C. A.; Lendvai, N.; Tai, Y. T.; Chang, S.; Moussa, D.; Buggy, J. J.; Elias, L.; Richardson, P. G. |
| Abstract Title: | Early changes in cytokines, chemokines and indices of bone metabolism in a phase 2 study of the bruton tyrosine kinase (Btk) inhibitor, ibrutinib (PCI-32765) in patients with relapsed or relapsed/refractory multiple myeloma (MM) |
| Meeting Title: | 54th Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 120 |
| Issue: | 21 |
| Meeting Dates: | 2012 Dec 8-11 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2012-11-01 |
| Language: | English |
| ACCESSION: | WOS:000314049603061 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V120.21.4039.4039 |
| Notes: | --- - Meeting Abstract: 4039 - 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) - DEC 08-11, 2012 - Atlanta, GA - "Source: Wos" |
